CRIZAC (CRIZAC) Fair Value & Analysis
Consumer Defensive · Market cap ₹35.0B
Fair value as of: Jul 3, 2026
From 26 valuation models · updated today
Share price −7.4% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹176.91 – ₹362.33 · fair‑value band ₹166.75 – ₹551.42 · the ₹200.07 price screens below the ₹219.20 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
CRIZAC (CRIZAC) currently trades at ₹200.07, while our model-based Fair Value estimate is ₹219.20 — implying the stock looks roughly 9.6% undervalued today. We read business quality at 56/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, CRIZAC generated revenue of ₹10.4B at a net margin of 21.0%. Revenue grew 15.0% year over year. It earns a return on equity of 40.0%. The balance sheet holds a net cash position of ₹1.6B. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
CRIZAC reported revenue of ₹10.4B in FY2026 versus ₹2.6B in FY2022, a compound +41.0%/yr. Reported net income was ₹2.2B in FY2026, compounding +34.1%/yr from FY2022.
Is CRIZAC fairly valued? → Check now
Similar stocks
6 more Education & Training Services stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| New Oriental Education & Technology Group EDUN | 966.48 MXN | 905.77 MXN | -6% |
| 9901 9901 | HK$36.30 | HK$4.84 | -87% |
| TAL Education Group T1AL34 | R$4.89 | R$0.9200 | -81% |
| Graham Holdings GHC | $1,147 | $1,170 | +2% |
| Laureate Education, Inc LAUR | $33.82 | $33.05 | -2% |
| Covista Inc CVSA | $119.28 | $137.46 | +15% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is CRIZAC (CRIZAC) undervalued?
What is the fair value of CRIZAC?
What is the quality score of CRIZAC?
What is the revenue of CRIZAC (CRIZAC)?
What is the net profit margin of CRIZAC?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.